Opiant Pharmaceuticals, Inc.(OPNT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OPNT Opiant Pharmaceuticals, Inc.

Halted 11-26 06:41:34 EST

20.65

+0.00

0.00%

High20.65	Low20.65	Vol0.00
Open20.65	D1 Closing20.65	Amplitude0.00%
Mkt Cap108.80M	Tradable Cap92.16M	Total Shares5.27M
T/O11.63M	T/O Rate0.00%	Tradable Shares4.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"OPNT","market":"US","secType":"STK","nameCN":"Opiant Pharmaceuticals, Inc.","latestPrice":20.65,"timestamp":1677704400000,"preClose":20.65,"halted":3,"volume":0,"delay":0,"floatShares":4462949,"shares":5268677,"eps":-6.624984,"marketStatus":"Halted","change":0,"latestTime":"11-26 06:41:34 EST","open":20.65,"high":20.65,"low":20.65,"amount":11627991.679858,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.624984,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732631400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":20.65,"volumeRatio":0},"requestUrl":"/m/hq/s/OPNT/wiki","defaultTab":"wiki","newsList":[{"id":"2337606790","title":"UPDATE 1-US FDA approves Opiant's spray for reversing opioid-related overdoses","url":"https://stock-news.laohu8.com/highlight/detail?id=2337606790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337606790?lang=en_us&edition=fundamental","pubTime":"2023-05-23 05:39","pubTimestamp":1684791576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OPNT"],"gpt_icon":0},{"id":"2337917605","title":"US FDA approves Opiant's overdose reversal spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2337917605","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337917605?lang=en_us&edition=fundamental","pubTime":"2023-05-23 05:04","pubTimestamp":1684789493,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OPNT","SANA","BK4082","LHDX","CGEM","BK4196","APR","BK4139","LABP"],"gpt_icon":0},{"id":"2337600186","title":"REUTERS NEWS SCHEDULE 10 p.m. GMT/6 a.m. SGT","url":"https://stock-news.laohu8.com/highlight/detail?id=2337600186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337600186?lang=en_us&edition=fundamental","pubTime":"2023-05-22 06:13","pubTimestamp":1684707187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU0976567544.SGD","BK4581","BMO","LU1261432733.SGD","BK4099","LU0211327993.USD","LU0149725797.USD","SG9999002232.USD","BK4550","IE00B1BXHZ80.USD","LU0170899867.USD","LU0320765646.SGD","LU0417517546.SGD","IE00BKVL7J92.USD","LU1496350502.SGD","JPM","BK4588","BK4574","BK4007","LU0971096721.USD","LU1668664300.SGD","LU0211328371.USD","IE00BZ1G4Q59.USD","BK4534","IE00BWXC8680.SGD","LU1244550494.USD","NWS","BK4100","BK4533","LU1496350171.SGD","BK4111","BK4555","OPNT","IE00B1XK9C88.USD","LU1363072403.SGD","BK4585","LU0211326839.USD","LU0496365809.HKD","BK4504","LU0882574139.USD","BK4207","SG9999002224.SGD","LU1244550577.SGD","LU0106831901.USD","LU1267930490.SGD","F","LU0070302665.USD","LU1162221912.USD","LU0211326755.USD"],"gpt_icon":0},{"id":"2337010656","title":"REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/6:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2337010656","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337010656?lang=en_us&edition=fundamental","pubTime":"2023-05-21 18:01","pubTimestamp":1684663306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU1267930490.SGD","LU0070302665.USD","ET","LU1496350171.SGD","BK4585","BK4007","BK4533","LU0211328371.USD","LU1989772840.SGD","IEA","LU1989772923.USD","LU1244550494.USD","LU0149725797.USD","OPNT","LU1363072403.SGD","SG9999002224.SGD","BK4144","JPM","LU0320765646.SGD","LU1244550577.SGD","LU1074936037.SGD","BK4207","LU0976567544.SGD","LU0417517546.SGD","BK4127","LU0971096721.USD","LU0882574139.USD","BK4550","LU1261432733.SGD","BK4111","LU0170899867.USD","LU0211327993.USD","LU0098860793.USD","IE00BZ1G4Q59.USD","LU1496350502.SGD","IE00BKVL7J92.USD","BK4129","LU0211326839.USD","NWS","BK4588","IE00B1BXHZ80.USD","BK4561","IE00BWXC8680.SGD","MS","LU0106831901.USD","IE00B1XK9C88.USD","LU1668664300.SGD","SG9999002232.USD","IE0034235188.USD"],"gpt_icon":0},{"id":"2330581153","title":"UPDATE 1-Indivior lowers profit outlook on Opiant deal costs, boosts sales view","url":"https://stock-news.laohu8.com/highlight/detail?id=2330581153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2330581153?lang=en_us&edition=fundamental","pubTime":"2023-04-27 19:49","pubTimestamp":1682596187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPNT"],"gpt_icon":0},{"id":"2330585474","title":"Indivior lifts 2023 net revenue outlook, lowers profit forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2330585474","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2330585474?lang=en_us&edition=fundamental","pubTime":"2023-04-27 19:15","pubTimestamp":1682594124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPNT"],"gpt_icon":0},{"id":"2313048244","title":"Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) largest shareholders are individual investors with 52% ownership, institutions own 33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2313048244","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2313048244?lang=en_us&edition=fundamental","pubTime":"2023-02-22 18:49","pubTimestamp":1677062940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/opiant-pharmaceuticals-inc-nasdaq-opnt-104900137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRCT","OPNT","BK4139","BK4191","TERN","BOLT","BK4007","BK4539"],"gpt_icon":0},{"id":"2310833983","title":"What's The Opiant CVR Worth? (NASDAQ:OPNT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2310833983","media":"Seeking Alpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2310833983?lang=en_us&edition=fundamental","pubTime":"2023-02-11 17:32","pubTimestamp":1676107939,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1Nzc1MDYtd2hhdHMtdGhlLW9waWFudC1jdnItd29ydGjSAQA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1Nzc1MDYtd2hhdHMtdGhlLW9waWFudC1jdnItd29ydGjSAQA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["OPNT","BK4161","NASDAQ","BK4007","CVR"],"gpt_icon":0},{"id":"2309531506","title":"Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2309531506","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2309531506?lang=en_us&edition=fundamental","pubTime":"2023-02-08 05:01","pubTimestamp":1675803660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/W4FN4YKWLZMY1wsmnl8DtA--~B/aD0xMzg7dz0yODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/42b9a5c270064450b25b120e0630b2b5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/W4FN4YKWLZMY1wsmnl8DtA--~B/aD0xMzg7dz0yODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/42b9a5c270064450b25b120e0630b2b5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/opiant-pharmaceuticals-announces-cfius-approval-210100542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PLC","OPNT","BK4007"],"gpt_icon":0},{"id":"2309395022","title":"Indivior Says Waiting Period for Opiant Pharmaceuticals Acquisition Expired","url":"https://stock-news.laohu8.com/highlight/detail?id=2309395022","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2309395022?lang=en_us&edition=fundamental","pubTime":"2023-02-06 21:42","pubTimestamp":1675690920,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRCT","OPNT","BK4191","TERN","BK4007","BK4539"],"gpt_icon":0},{"id":"2309393462","title":"Press Release: Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2309393462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2309393462?lang=en_us&edition=fundamental","pubTime":"2023-02-06 21:00","pubTimestamp":1675688400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLC","OPNT","BK4007"],"gpt_icon":0},{"id":"2306406547","title":"Aerojet ticks lower amid Sen. Elizabeth Warren call for FTC to block L3Harris deal (update)","url":"https://stock-news.laohu8.com/highlight/detail?id=2306406547","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2306406547?lang=en_us&edition=fundamental","pubTime":"2023-01-28 01:23","pubTimestamp":1674840196,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385501568/image_1385501568.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385501568/image_1385501568.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3929001-aerojet-ticks-lower-amid-sen-elizabeth-warren-call-for-ftc-to-block-l3harris-deal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU0868494617.USD","LU1162221912.USD","BK4566","LHX","LU1244550221.USD","BK4585","BK4007","BK4533","LU1244550494.USD","LU2242652126.USD","LU2264538146.SGD","OPNT","BK4581","LU0058720904.USD","BK4532","LU0320765646.SGD","LU1244550577.SGD","LU1988902786.USD","BK4534","LU0289739699.SGD","LU1064131342.USD","BK4516","BK4564","LU0109394709.USD","LU0889565916.HKD","LU2242646821.SGD","NOC","LU0320765992.SGD","AMGN","BK4139","AJRD","HZNP","BK4187","LMT"],"gpt_icon":0},{"id":"2306197416","title":"Horizon Pharma, Opiant fall amid Elizabeth Warren concern about pharma deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2306197416","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2306197416?lang=en_us&edition=fundamental","pubTime":"2023-01-27 03:45","pubTimestamp":1674762355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1328507495/image_1328507495.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1328507495/image_1328507495.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3928615-horizon-pharma-opiant-fall-on-report-elizabeth-warren-concerned-about-pharma-deals","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MNQmain","BK4139","LU0109394709.USD","LU0289739699.SGD","BK4113","PSQ","BK4533","QLD","HZNP","LU0320765992.SGD","LU2242652126.USD","BK4125","LU0058720904.USD","BK4581","BK4504","BK4532","AMGN","BK4566","BK4534","TQQQ","INVVY","ACI","LU2242646821.SGD","LU0889565916.HKD","SQQQ","QQQ","QID","BK4585","KR",".IXIC","OPNT","BK4559","NQmain","LU0868494617.USD","BK4007","TGNA"],"gpt_icon":0},{"id":"2306492042","title":"Warren tells FTC she is \"particularly concerned\" about Amgen and Indivior deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2306492042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2306492042?lang=en_us&edition=fundamental","pubTime":"2023-01-27 01:07","pubTimestamp":1674752858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0289739699.SGD","LU0889565916.HKD","BK4139","BK4585","OPNT","BK4007","HZNP","BK4534","LU0868494617.USD","LU0320765992.SGD","LU2242646821.SGD","LU2242652126.USD","LU0109394709.USD","LU0058720904.USD","BK4581","BK4532","AMGN","BK4566"],"gpt_icon":0},{"id":"2304793178","title":"Opiant wins FDA priority review for opioid overdose therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2304793178","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304793178?lang=en_us&edition=fundamental","pubTime":"2023-01-20 19:49","pubTimestamp":1674215393,"startTime":"0","endTime":"0","summary":"Specialty pharma company Opiant Pharmaceuticals  announced that the FDA accepted its New Drug Application  for nasal opioid overdose therapy OPNT003, granting it the agency’s Priority Review designation. The FDA has issued May 22, 2023, as the target action date for its decision speeding up the review period from ten months to six months.  A nasal drug comprising the high-affinity opioid antagonist nalmefene, OPNT003 has undergone several pharmacokinetic  and pharmacodynamic studies, the results","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413289936/image_1413289936.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3926254-opiant-wins-fda-priority-review-for-opioid-overdose-therapy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["PK","INVVY","OPNT","BK4007","BK4181"],"gpt_icon":0},{"id":"2304851673","title":"BRIEF-Opiant Pharmaceuticals Announces FDA Acceptance And Priority Review Of NDA For OPTN003","url":"https://stock-news.laohu8.com/highlight/detail?id=2304851673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304851673?lang=en_us&edition=fundamental","pubTime":"2023-01-20 05:06","pubTimestamp":1674162384,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LHDX","LABP","BK4023","SANA","APR","BK4007","CGEM","BK4139","BK4196","OPNT","BK4082","ONTF"],"gpt_icon":0},{"id":"2304667800","title":"Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose","url":"https://stock-news.laohu8.com/highlight/detail?id=2304667800","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304667800?lang=en_us&edition=fundamental","pubTime":"2023-01-20 05:05","pubTimestamp":1674162300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/W4FN4YKWLZMY1wsmnl8DtA--~B/aD0xMzg7dz0yODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/42b9a5c270064450b25b120e0630b2b5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/W4FN4YKWLZMY1wsmnl8DtA--~B/aD0xMzg7dz0yODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/42b9a5c270064450b25b120e0630b2b5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/opiant-pharmaceuticals-announces-fda-acceptance-210500729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HHS","BK4539","CRCT","BK4007","ASPR","BK4009","BK4181","OPNT","PK","TERN","BK4191"],"gpt_icon":0},{"id":"2286348785","title":"Opiant Pharmaceuticals (OPNT) Stock Receives $22 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2286348785","media":"Pulse 2.0","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2286348785?lang=en_us&edition=fundamental","pubTime":"2022-11-28 06:32","pubTimestamp":1669588333,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/__i/rss/rd/articles/CBMiTmh0dHBzOi8vcHVsc2UyLmNvbS9vcGlhbnQtcGhhcm1hY2V1dGljYWxzLW9wbnQtc3RvY2stcmVjZWl2ZXMtMjItcHJpY2UtdGFyZ2V0L9IBAA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.google.com/__i/rss/rd/articles/CBMiTmh0dHBzOi8vcHVsc2UyLmNvbS9vcGlhbnQtcGhhcm1hY2V1dGljYWxzLW9wbnQtc3RvY2stcmVjZWl2ZXMtMjItcHJpY2UtdGFyZ2V0L9IBAA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["BK4532","LU1244550577.SGD","LU1244550221.USD","BK4504","BK4007","BK4585","TGT","BK4114","LU1244550494.USD","OPNT","BK4533","LU0823411888.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.opiant.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.013469},{"month":2,"riseRate":0.666667,"avgChangeRate":0.035864},{"month":3,"riseRate":0,"avgChangeRate":-0.129857},{"month":4,"riseRate":0.6,"avgChangeRate":0.040411},{"month":5,"riseRate":0.4,"avgChangeRate":-0.094695},{"month":6,"riseRate":0.4,"avgChangeRate":-0.049426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.002853},{"month":8,"riseRate":0.8,"avgChangeRate":0.187011},{"month":9,"riseRate":0.5,"avgChangeRate":0.01966},{"month":10,"riseRate":0.5,"avgChangeRate":-0.032042},{"month":11,"riseRate":0.5,"avgChangeRate":0.161431},{"month":12,"riseRate":0.5,"avgChangeRate":0.001008}],"exchange":"NASDAQ","name":"Opiant Pharmaceuticals, Inc.","nameEN":"Opiant Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Opiant Pharmaceuticals, Inc.(OPNT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Opiant Pharmaceuticals, Inc.(OPNT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Opiant Pharmaceuticals, Inc.,OPNT,Opiant Pharmaceuticals, Inc.股票,Opiant Pharmaceuticals, Inc.股票老虎,Opiant Pharmaceuticals, Inc.股票老虎国际,Opiant Pharmaceuticals, Inc.行情,Opiant Pharmaceuticals, Inc.股票行情,Opiant Pharmaceuticals, Inc.股价,Opiant Pharmaceuticals, Inc.股市,Opiant Pharmaceuticals, Inc.股票价格,Opiant Pharmaceuticals, Inc.股票交易,Opiant Pharmaceuticals, Inc.股票购买,Opiant Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Opiant Pharmaceuticals, Inc.(OPNT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Opiant Pharmaceuticals, Inc.(OPNT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}